{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:41:36Z","timestamp":1790484096181,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.medmal.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T10:26:34Z","timestamp":1465899994000},"page":"406-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Analysis of the 2015 American and European guidelines for the management of infective endocarditis"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-5411","authenticated-orcid":false,"given":"P.","family":"Tattevin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Mainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.medmal.2016.05.008_bib0005","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"44","key":"10.1016\/j.medmal.2016.05.008_bib0010","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.medmal.2016.05.008_bib0015","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.medmal.2016.05.008_bib0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.medmal.2016.05.008_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000441-197703000-00002","article-title":"Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin","volume":"273","author":"Watanakunakorn","year":"1977","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.medmal.2016.05.008_bib0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/infdis\/131.4.367","article-title":"Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus","volume":"131","author":"Sande","year":"1975","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.medmal.2016.05.008_bib0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.47.1.418-420.2003","article-title":"In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus","volume":"47","author":"Grohs","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.medmal.2016.05.008_bib0040","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10096-011-1458-9","article-title":"A survey on the use of gentamicin in infective endocarditis","volume":"31","author":"Beraud","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.medmal.2016.05.008_bib0045","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.medmal.2016.05.008_bib0050","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/jac\/dkt294","article-title":"A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis","volume":"68","author":"Kullar","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.medmal.2016.05.008_bib0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.medmal.2016.05.008_bib0060","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/AAC.39.9.1984","article-title":"Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis","volume":"39","author":"Mainardi","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.medmal.2016.05.008_bib0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijantimicag.2013.05.002","article-title":"Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim\/sulfamethoxazole and clindamycin \u2013\u00a0preliminary report","volume":"42","author":"Casalta","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.medmal.2016.05.008_bib0070","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim\u2013sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2016.05.008_bib0075","first-page":"h2219","article-title":"Trimethoprim\u2013sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial","volume":"350","author":"Paul","year":"2015","journal-title":"BMJ Clin Res Ed"},{"issue":"3","key":"10.1016\/j.medmal.2016.05.008_bib0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9343(76)90758-0","article-title":"Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin","volume":"60","author":"Watanakunakorn","year":"1976","journal-title":"Am J Med"},{"issue":"19","key":"10.1016\/j.medmal.2016.05.008_bib0085","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.medmal.2016.05.008_bib0090","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","article-title":"Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?","volume":"17","author":"Paul","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.medmal.2016.05.008_bib0095","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis","volume":"56","author":"Fernandez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.medmal.2016.05.008_bib0100","doi-asserted-by":"crossref","first-page":"O1075","DOI":"10.1111\/1469-0691.12756","article-title":"Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone","volume":"20","author":"Pericas","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X1630049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X1630049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:14:18Z","timestamp":1759972458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X1630049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0399077X1630049X"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2016.05.008","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the 2015 American and European guidelines for the management of infective endocarditis","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}